Live on Wednesdays 9AM PST, 12PM EST, 4PM GMT


Website LINK:

Q&A via TWITTER with #globalimmuno (contingent on speaker availability)

All talks are recorded and uploaded in YouTube channel named “Global Immunotalks”

Recent ICIS Member highlighted presentations from


Understanding the paradoxical effects of obesity on the immune system by Dr. Lydia Lynch, May 12, 2022

Human type I interferonopathies by Dr. Yanick Crow, April 27, 2022

The discovery of group 2 innate lymphoid cells by Dr. Kazuyo Moro, Osaka University; RIKEN Center for Integrative Medical Sciences (IMS), March 30, 2022 (ILC4 Speaker)

Immunological uniqueness of brain borders by Jonathan Kipnis, Washington University St. Louis, USA (Cytokines 2022 Speaker)

Immunometabolism in inflammation and coagulation by Dr. Luke O’Neill, Trinity College Dublin, February 23, 2022

Oh To Be Seventeen Again: Two (+) Decades of IL-17 Signaling by Dr. Sarah Gaffen, University of Pittsburgh, March 10, 2022

Immune responses to SARS-CoV-2 by Dr. Akiko Iwasaki, Yale University, October 20, 2021

Alarming controversies in IL-33 biology by Dr. De’Broski Herbert, University of Pennsylvania (Penn Vet), November 3, 2021

Type 2 immunity: learning from helminths by Dr. Judith Allen University of Manchester – September 29, 2021

Pyroptosis in antibacterial & antitumor immunity by Dr. Feng Shao, National Institute of Biological Sciences, Beijing – August 18, 2021

T cell regulation in immunity and diseases by Dr. Chen Dong, Tsinghua University, Beijing – August 4, 2021

CD4 T cell memory in the lungs by Dr. Marion Pepper, University of Washington, Seattle – May 12, 2021

Translating immunology into new therapies for Inflammatory Bowel Disease by Dr. Fiona Powrie, University of Oxford, John Radcliffe Hospital – March 24, 2021

GM-CSF communication conduit between lymphocytes & myeloid cells in inflammation Dr. Burkhard Becher, University of Zurich Institute of Experimental Immunology – February 3, 2021

Supplying the T cell generation pipeline by gene regulation by Dr. Ellen Rothenberg, Caltech – January 27, 2021

A humanized mouse model for COVID-19: Infection and Pathogenesis by Dr. Richard Flavell, Yale Univ School of Med – January 13, 2021

ILC2s, innate allergy, and tissue resilience by Dr. Richard Locksley, University of California, San Francisco – December 9, 2020

Adapting to a viral infection by Dr. Elina Zuniga, University of California, San Diego – August 5, 2020

Limiting Infection-Induced Inflammation by Dr. Christopher Hunter, University of Pennsylvania School of Veterinary Medicine – July 8, 2020

Phosphatidylserine sensing in life and death by Dr. Carla Rothlin, Yale University School of Medicine – July 1, 2020


The Offensive Side of Immune Defenses; DNA sensing pathways by Dr. Kate Fitzgerald, University of Massachusetts – June 10, 2020

Microbiota control of tissue immunity by Dr. Yasmine Belkaid, NIH – May 13, 2020